Want to track CYAD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
CYAD closed today higher at €0.21, an increase of 3.8835% from yesterday's close, completing a monthly decrease of -4.4643% or -€0.01. Over the past 12 months, CYAD stock gained 12.6316%.
CYAD is not paying dividends to its shareholders.
The last earnings report, released on May 08, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on XBRU (EUR).
CYAD Chart
Celyad Oncology SA (CYAD) FAQ
What is the stock price today?
The current price is €0.21.
On which exchange is it traded?
Celyad Oncology SA is listed on XBRU.
What is its stock symbol?
The ticker symbol is CYAD.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, no market cap data is available.
Has Celyad Oncology SA ever had a stock split?
No, there has never been a stock split.
Celyad Oncology SA Profile
| Biotechnology Industry | Healthcare Sector | - CEO | XBRU Exchange | BE0974260896 ISIN |
| France Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Contact Information
Address: -
Phone: -
2026 © Marketlog. All Rights Reserved.
